계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
Frequency Therapeutics
company
About
Frequency Therapeutics develops small molecule drugs that activate progenitor cells within the body to restore healthy tissue.
- 51 - 100
Details
- Last Funding Type
- Post-IPO Equity
- Last Funding Money Raised
- $42.30M
- Industries
- Biotechnology,Genetics,Medical
- Founded date
- Jan 1, 2015
- Number Of Employee
- 51 - 100
- Operating Status
- Active
Frequency Therapeutics develops small molecule drugs that activate progenitor cells within the body to restore healthy tissue. Through the transitory activation of these progenitor cells, Frequency enables disease modification without the complexity of genetic engineering. It was founded in 2015 and headquartered in Woburn, Massachusetts.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
4
$74.30M
Frequency Therapeutics has raised a total of
$74.30M
in funding over 2 rounds. Their latest funding was raised on
Jul 17, 2020 from a Post-IPO Equity round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jul 17, 2020 | Post-IPO Equity | $42.30M | 1 | — | — | Detail |
| Jul 23, 2019 | Series C | — | 1 | — | — | Detail |
| Jan 7, 2019 | Series B | — | 1 | — | — | Detail |
| Apr 11, 2017 | Series A | $32M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
3
Frequency Therapeutics is funded by 3 investors.
Maven Investment Partners US
and Polaris Founders Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Post-IPO Equity |
Polaris Founders Capital
|
— | Series C |
Emigrant Capital
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
